[1]张 波.冠心病心绞痛患者血浆同型半胱氨酸水平与 中医证候要素痰、瘀的回归性研究[J].医学信息,2018,31(16):142-144.[doi:10.3969/j.issn.1006-1959.2018.16.045]
　ZHANG Bo.A Regression Study of Plasma Homocysteine Level and Phlegm and Blood Stasis in Patients with Angina Pectoris of Coronary Heart Disease[J].Journal of Medical Information,2018,31(16):142-144.[doi:10.3969/j.issn.1006-1959.2018.16.045]
点击复制

冠心病心绞痛患者血浆同型半胱氨酸水平与 中医证候要素痰、瘀的回归性研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年16期
页码:
142-144
栏目:
中医中药
出版日期:
2018-08-15

文章信息/Info

Title:
A Regression Study of Plasma Homocysteine Level and Phlegm and Blood Stasis in Patients with Angina Pectoris of Coronary Heart Disease
文章编号:
1006-1959（2018）16-0142-03
作者:
张 波
南京中医药大学附属南京市中西医结合医院科教科，江苏 南京 210014
Author(s):
ZHANG Bo
Department of Science and Education,Nanjing Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210014,Jiangsu,China
关键词:
冠心病; 证候要素; 痰; 瘀; 同型半胱氨酸
Keywords:
Key words：Coronary heart disease; Syndromes; Phlegm; Blood stasis; Homocysteine
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2018.16.045
文献标志码:
A
摘要:
目的 研究冠心病心绞痛患者血浆同型半胱氨酸水平与中医证候要素痰、瘀的回归性。方法 收集冠心病心绞痛患者共227例，检测血浆同型半胱氨酸，采集四诊信息并按中医证候要素痰、瘀进行辨证积分分类，并对四组指标采用2×2析因分析及线性回归分析。结果 冠心病患者各证候要素组间Hcy水平依次为：痰瘀互结组＞血瘀组＞痰浊组＞无痰无瘀组；以Hcy为应变量，痰证积分（≥20部分）为自变量做一元线性回归可知，冠心病患者血浆Hcy水平与痰证积分≥20的部分呈线性相关；以Hcy为应变量，瘀证积分为自变量做一元线性回归可知，冠心病患者血浆Hcy水平与瘀证积分成线性相关，即瘀证积分越高，Hcy水平越高。结论 Hcy水平与中医证素“痰”“瘀”皆存在线性相关，Hcy可作为评估冠心病患者“痰”证严重程度的客观化指标，并可作为中医冠心病中医“瘀”证辨证的客观化指标。
Abstract:
Abstract：Objective To do the regression study on plasma homocysteine level and TCM syndrome factors phlegm and blood stasis in patients with coronary heart disease and angina pectoris.Methods 227 patients with angina pectoris of coronary heart disease were collected, plasma homocysteine was detected,the information of four diagnoses was collected and made a dialectical score classification according to phlegm and blood stasis of TCM syndromes,and 2×2 factorial analysis and linear regression analysis were used for the four groups of indexes.Results The levels of Hcy among the syndromes of patients with coronary heart disease were as follows:phlegm and blood stasis group>blood stasis group>phlegm turbidity group>no phlegm and blood stasis group.Taking Hcy as the dependent variable and the integral of phlegm syndrome(≥20 parts)as independent variables,we made a linear regression analysis,the plasma Hcy level in patients with coronary heart disease is linearly related to the level of phlegm syndrome score≥20.Taking Hcy as the dependent variable and the integral of stasis syndrome as independent variable,we made a linear regression analysis.The plasma Hcy level in patients with coronary heart disease is linearly related to the integral of stasis syndrome,that is,the higher the stasis syndrome score is,the higher the Hcy level is.Conclusion The level of Hcy is linearly related to the TCM syndrome"phlegm"and "blood stasis".Hcy can be used as an objective index to evaluate the severity of phlegm syndrome in patients with coronary heart disease,and can be used as an objective index for syndrome differentiation of TCM"stasis"syndrome of coronary heart disease.

参考文献/References:

[1] 朱文峰.证素辨证学[M].北京:人民卫生出版社,2008.
[2]Tsai MY.Laboratory assessment of mild hyperhomocysteinemia as an independent risk factor for occlulsive vascular diseases[J].Clin Chem,1996,42(4):492-493.
[3]Chasan-Taber L,Selhub S,Rosenberg IH,et a1.A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians[J].JAm Coll Nutr,1996,15(2):136-142.
[4] 宋兆言,李京秀,郭龙哲,等.同型半胱氨酸与冠状动脉粥样硬化性心脏病相关性研究进展[J].新乡医学院学报，2018,35(4):347-351.
[5] 赵立诚,富蓉,冼绍祥,等.冠心病心血瘀阻证微观诊断的研究进展[J].广州中医药大学学报,1999,16(3):241-243.
[6] 王玉晓.豁痰化瘀方联合西药对冠心病非经皮冠状动脉介入治疗患者血浆同型半胱氨酸水平的影响[J].中医杂志,2016,57(10):852-855.

相似文献/References:

[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
　YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(16):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(16):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
　ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(16):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及 对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
　ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(16):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
　XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(16):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与 冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
　WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(16):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及 对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
　MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(16):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与 冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
　YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(16):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(16):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(16):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]

更新日期/Last Update: 2018-08-15